X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Press Statements

Final Report ACHEMA 2022

Content Team by Content Team
19th September 2022
in Press Statements

High internationality, satisfied exhibitors, significantly higher attendee numbers at the congress

At ACHEMA 2022, the world’s leading trade show for the process industry, over 2,200 exhibitors from more than 50 countries showcased the latest equipment and innovative processes for the chemical, pharmaceutical and food industries at the Frankfurt fairgrounds from 22 to 26 August.

Exhibition Groups

The exhibition group “Pumps, Compressors, Valves and Fittings” comprised the most exhibitors at ACHEMA 2022, followed by “Pharmaceutical, Packaging and Storage Techniques” and ” Instrumentation, Control and Automation Techniques”. A new addition to the exhibition group is the “Digital Hub” as a central meeting place for digital experts and players in digitalization.

Internationality

After Germany (1,042 exhibitors), Italy (179 exhibitors) and India (143 exhibitors) showed the largest exhibitor participation. Despite existing travel restrictions, 74 exhibitors from China also took part in ACHEMA 2022. At 52.9 %, the foreign share on the exhibitor side remained at an unchanged high level.

Atmosphere

The products and technologies presented met with great interest from the audience: The stands in the halls were well attended and the fairgrounds were bustling with activity. “The need for personal exchange is huge after such a long time. The exhibitors we spoke to and we ourselves had a successful trade show, where we held numerous discussions with direct project or investment relevance,” confirms Jürgen Nowicki, Chairman of the ACHEMA Committee and CEO of Linde Engineering.

Volker Huelsekopf, Head of Sales & Marketing, smartGAS, shares this impression: “The anticipation of the first ACHEMA in four years was worthwhile. After a long break, we were again able to reach many of our customers and interested visitors in personal discussions. This once again confirms ACHEMA’s importance for us as the leading trade show for process measurement technology.”

The three focal topics of ACHEMA 2022 also met with great interest. At the “Digital Lab”, the smart laboratory of tomorrow could be experienced at the stands in the field of laboratory and analytical technology and at the associated action area.

Many new developments in the exhibition halls took up the focus topic “Modular and Connected Production”: The trend towards designing production lines in the chemical and pharmaceutical industry with the greatest possible flexibility and fully networking them was reflected in numerous innovations on the stands in the different exhibition groups.

With “Product and Process Security”, ACHEMA 2022 also took up the topic of digital security, which is becoming increasingly important for many companies in times of industry 4.0, networked production and in view of the high threat level posed by cyberattacks: Over 330 exhibitors presented their products and services on this topic, which also forms the link to the new “Digital Hub” exhibition group as a central meeting point for digital experts and players in digitalization.

“The best part of being at ACHEMA in person is promoting digitalization tools with hands-on demonstrations. This is much harder to do virtually than at ACHEMA, where we can meet with clients and partners to discuss specific solutions to their challenges”, emphasizes Helen Bartmann, project manager for digitalization projects at Actemium.

Attendees

ACHEMA 2022 was attended by 70,007 participants from 127 nations. Approximately every second attendee (46.4%) at the trade show came from abroad. “This year, I was curious how ACHEMA 2022 would develop with the pandemic and the current business situation, but we have been quite surprised and happy about today’s quantity and quality of visitors”, says Claus Weihermueller, Business Development & Project Pursuit at Flexim.

Congress

The ACHEMA Congress covered the entire spectrum of chemical process technology and biotechnology. The lectures provided insights into current research and development projects as well as the latest scientific results.

On each day of the trade show, particularly topical issues were dealt with in a separate theme day:

  • Hydrogen Economy (Monday, 22 August)
  • Fossil-free Production (Tuesday, 23 August)
  • Perspectives in Laboratory and Analytics (Wednesday, 24 August)
  • Digitalization in the Process Industry (Thursday, 25 August)
  • Novel Bioprocesses and Technologies (Friday, 26 August).

Daily highlight sessions within the respective themes emphasized additional topics. In the congress programme, the hydrogen topic as well as lectures on sustainability, the circular economy and digitalization met with particularly great interest. “The dovetailing of congress and exhibition is a complete success: with more than 20,000 listeners, the attendance figures are significantly higher than at the last ACHEMA in 2018, which had more participants overall. And the feedback from congress attendees is also positive,” says Dr Andreas Förster, Executive Director of DECHEMA e.V. “We will expand the concept with a view to the next ACHEMA.”

Perspective

The next ACHEMA will take place in Frankfurt from 10 to 14 June 2024.

Previous Post

Australia Gives Nod To A New Cholangiocarcinoma Treatment

Next Post

Neuron23, QIAGEN To Create First Next-Gen Parkinson's Drug

Related Posts

Americas

Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn

4th March 2025
Drug Development

Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

4th March 2025
Drug Development

Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

4th March 2025
Press Statements

Saudi Arabia Poised to Expand Domestic Manufacturing Eco-system as 30,000 Attendees join Inaugural CPHI Middle East

11th December 2024
Press Statements

Pharma Contract Manufacturing 2025

7th December 2024
Press Statements

Asahi Kasei Microdevices Advances AgeTech with Better AI-Ready Data Through New Sensor Technologies – Devices will be demonstrated at CES 2025, showing how aging in place can be safer and more accessible

18th November 2024
Next Post
Neuron23, QIAGEN To Create First Next-Gen Parkinson’s Drug

Neuron23, QIAGEN To Create First Next-Gen Parkinson's Drug

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In